EXX5:F:F-iShares Dow Jones U.S. Select Dividend UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 86.7

Change

-0.19 (-0.22)%

Market Cap

N/A

Volume

1.16K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.03 (-0.09%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.05 (+0.10%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.60 (+0.25%)

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.05B
VUSA:F Vanguard Funds Public Limited ..

+0.24 (+0.24%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.28 (+0.28%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.74B
0ZC:F Zscaler Inc

-3.78 (-2.48%)

USD 37.92B

ETFs Containing EXX5:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.09% 69% C- 66% D+
Dividend Return 1.60% 10% F 19% F
Total Return 15.69% 70% C- 61% D-
Trailing 12 Months  
Capital Gain 21.33% 65% D 65% D
Dividend Return 2.44% 13% F 23% F
Total Return 23.77% 68% D+ 59% D-
Trailing 5 Years  
Capital Gain 34.09% 54% F 60% D-
Dividend Return 2.70% 39% F 7% C-
Total Return 36.78% 56% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 9.86% N/A N/A 69% C-
Dividend Return 10.19% N/A N/A 62% D
Total Return 0.33% N/A N/A 13% F
Risk Return Profile  
Volatility (Standard Deviation) 19.47% N/A N/A 65% D
Risk Adjusted Return 52.33% N/A N/A 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike